ePrints

Acquired C1-inhibitor deficiency presenting with nephrotic syndrome

Lookup NU author(s): Dr Jamie Willows, Dr Katrina Wood, Dr Helen Bourne, Professor John SayerORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.Acquired C1-inhibitor (C1-INH) deficiency is a rare and potentially life-threatening disorder, which presents with recurrent attacks of non-pitting oedema to the face, airway, limbs or gastrointestinal tract. It is often associated with underlying B-cell lymphoproliferative disorders. We describe a case of a 73-year-old man with acquired C1-INH deficiency who presented with nephrotic syndrome due to glomerular IgM deposition, secondary to an underlying secretory lymphoplasmacytic lymphoma. Both the acquired C1-INH deficiency and the nephrotic syndrome resolved when the underlying B-cell lymphoma was treated with rituximab and bendamustine, suggesting the underlying lymphoproliferative malignancy was driving both disorders.

Publication metadata

Author(s): Willows J, Wood K, Bourne H, Sayer JA

Publication type: Article

Publication status: Published

Journal: BMJ case reports

Year: 2019

Volume: 12

Issue: 7

Online publication date: 11/07/2019

Acceptance date: 26/06/2019

ISSN (electronic): 1757-790X

Publisher: NLM (Medline)

URL: https://doi.org/10.1136/bcr-2019-230388

DOI: 10.1136/bcr-2019-230388

PubMed id: 31300605

Altmetrics

Share